ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Mortality"

  • Abstract Number: 1287 • ACR Convergence 2020

    Prevalence of Morbidity Prior to Diagnosis of Incident Systemic Lupus Erythematosus in the Danish Population

    Julia Simard1, Mikkel Faurschou2, Soeren Jacobsen2 and Renata Hansen2, 1Stanford Medicine, Stanford, CA, 2Copenhagen Lupus and Vasculitis Clinic, Copenhagen, Denmark

    Background/Purpose: Patients with SLE experience a high burden of various comorbidities at disease onset and during disease progression. Studies of excess morbidity prior to SLE…
  • Abstract Number: 0487 • ACR Convergence 2020

    Association Between an Extended Lifestyle Score and Adverse Health-related Outcomes in People with Rheumatoid Arthritis: A Study of 5295 UK Biobank Participants

    Jordan Canning1, Stefan Siebert2, Bhautesh Jani1, Frances Mair1 and Barbara Nicholl1, 1University of Glasgow, Glasgow, Scotland, United Kingdom, 2University of Glasgow, Glasgow, United Kingdom

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterised by inflammation of the synovial joints. Traditional lifestyle factors, such as smoking and poor diet,…
  • Abstract Number: 1390 • ACR Convergence 2020

    Outcomes of Systemic Sclerosis Patients Who Were Primarily Admitted for Acute Myocardial Infarction from 2016 to 2017: Insights from the National Inpatient Sample

    Atefeh Vafa1, Omid Behnamfar2 and Yih Chang Lin3, 1University of South Florida, Tampa, FL, 2University of California San Diego, La Jolla, CA, 3University of South Florida, Morsani College of Medicine, Tampa, FL

    Background/Purpose: Several systemic autoimmune rheumatic diseases have been shown to increase coronary artery disease (CAD) risk, notable rheumatoid arthritis and systemic lupus erythematosus.  However, data…
  • Abstract Number: 0489 • ACR Convergence 2020

    Prevalence, Incidence, and Cause-Specific Mortality of Rheumatoid Arthritis-Associated Interstitial Lung Disease Among Older Patients with Rheumatoid Arthritis: A Nationwide Cohort Study

    Jeffrey Sparks1, Yinzhu Jin1, Soo-Kyung Cho2, Seanna Vine1, Rishi Desai1, Tracy J. Doyle3 and Seoyoung Kim1, 1Brigham and Women's Hospital, Boston, MA, 2Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea, 3Brigham and Women's Hospital, West Roxbury, MA

    Background/Purpose: Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) is one of the most serious extra-articular RA manifestations and is more common in older patients. Registry-based RA-ILD…
  • Abstract Number: 1423 • ACR Convergence 2020

    Declining In-Hospital Mortality in Vasculitis: A 17-year U.S. National Study

    Jasvinder Singh1 and John Cleveland1, 1University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: To our knowledge, only a few population-based studies for vasculitis mortality exist; and most are limited to vasculitis sub-types. Therefore, our study objective was…
  • Abstract Number: 0549 • ACR Convergence 2020

    Developing an Algorithm for Identifying Mortality in MarketScan Claims Data Using Machine Learning

    Fenglong Xie1, Hong Zhao1, Huifeng Yun2, Sasha Bernatsky3 and Jeffrey R Curtis2, 1University of Alabama at Birmingham, Birmingham, AL, 2Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 3The Research Institute of the McGill University Health Centre, Montreal, ON, Canada

    Background/Purpose: In 2016, MarketScan data no longer included information about inpatient mortality, compromising the ability to study fatal hospitalization events. Using data through 2015 when…
  • Abstract Number: 1424 • ACR Convergence 2020

    Outcomes of Hospitalizations for Acute Myocardial Infarction in Patients with ANCA Associated Vasculitis from the National Inpatient Sample

    Atefeh Vafa1, Marielys Figueroa Sierra1, Omid Behnamfar2, Hamayon Babary1, Suraiya Afroz1 and Yih Chang Lin3, 1University of South Florida, Tampa, FL, 2University of California San Diego, La Jolla, CA, 3University of South Florida, Morsani College of Medicine, Tampa, FL

    Background/Purpose: Several studies in the past have shown significantly increased risks of cardiovascular disease in patients with ANCA associated vasculitis (AAV). This association is thought…
  • Abstract Number: 0560 • ACR Convergence 2020

    Mortality Burden of Immune-Mediated Inflammatory Diseases (IMID): Race/Ethnicity, Sex, and Geographic Variation in the United States

    Ram Singh1, Eric Yen2 and Meifang Wu2, 1UCLA David Geffen School of Medicine, Los Angeles, CA, 2UCLA, Los Angeles, CA

    Background/Purpose: Almost every organ system can be affected by immune-mediated inflammatory diseases (IMID) characterized by inflammation and therapeutic response to immune-suppressive or anti-inflammatory drugs. Since…
  • Abstract Number: 1436 • ACR Convergence 2020

    Incidence Rate, Predictors and Outcome of Stroke in Patients with ANCA Associated Vasculitis – A Population-based Study

    Dennis Tabakovic1, Rona Smith2, David Jayne3 and Aladdin Mohammad4, 1Lund University, Lund, Skane Lan, Sweden, 2University of Cambridge, Cambridge, United Kingdom, 3Department of Medicine, Vasculitis and Lupus Research Group, University of Cambridge, Cambridge, UK, Cambridge, United Kingdom, 4Lund University, Lund, Sweden. Department of Medicine, Vasculitis and Lupus Research Group, University of Cambridge, Cambridge, UK, Lund, Sweden

    Background/Purpose: To study the incidence rate, predictors and outcome of stroke in patients with ANCA-associated vasculitis (AAV) within a defined population in southern Sweden.Methods: The…
  • Abstract Number: 0592 • ACR Convergence 2020

    A Rheumatology-Driven Protocol and Treatment Algorithm of SARS-CoV-2 Cytokine Release Syndrome and Its Associated Outcomes

    Sandy Lee1, Neha Chiruvolu2, Muntarin Karim3, Patil Injean4, Loomee Doo5, Donna Jose6, Deepa Panikkath1, Micah Yu5, Anna Lafian5, Wendy De La Pena7, Albert Chow8, Karina Torralba9, Vaneet Sandhu10, Mehrnaz Hojjati5, Marven Cabling5 and Christina Downey1, 1Loma Linda University Medical Center, Redlands, CA, 2UC Riverside School of Medicine, Riverside, CA, 3Loma Linda University Health System, Loma Linda, CA, 4LOMA LINDA UNIVERSITY MEDICAL CENTER - RHEUMATOLOGY, Redlands, CA, 5Loma Linda University Medical Center, LOMA LINDA, CA, 6Loma Linda University Medical Center, Ontario, CA, 7PRCSG, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 8Loma Linda University, San Bernardino, CA, 9Loma Linda University School of Medicine, Redlands, CA, 10Loma Linda University, Loma Linda, CA

    Background/Purpose: The newly identified SARS-CoV-2 has brought Cytokine Release Syndrome (CRS) to a level of prominence not often seen in adult medicine. Mortality rates of…
  • Abstract Number: 1468 • ACR Convergence 2020

    The Association of Walking Speed from Short- and Standard-Distance Tests with Mortality Risk Among Adults with Radiographic Knee Osteoarthritis: Data from Johnston County Osteoarthritis Project, Osteoarthritis Initiative and Multicenter Osteoarthritis Study

    Hiral Master1, Tuhina Neogi2, Leigh Callahan3, Amanda Nelson4, Michael LaValley5, Rebecca Cleveland6, Yvonne Golightly7, Louise Thoma8, Yuqing Zhang9, Dana Voinier10, Meredith Christiansen11, Jason Jakiela10, Michael Nevitt12, Cora Lewis13, Laura Frey Law14 and Daniel White10, 1Vanderbilt University Medical Center, Nashville, TN, 2Boston University School of Medicine, Boston, MA, 3University of North Carolina Thurston Arthritis Research Center, Chapel Hill, NC, 4University of North Carolina Chapel Hill, Chapel Hill, 5Boston University School of Public Health, Boston, MA, 6University of North Carolina, Chapel Hill, NC, 7University of North Carolina at Chapel Hill Dept of Epidemiology, Chapel Hill, NC, 8University of North Carolina at Chapel Hill, Chapel Hill, NC, 9Massachusetts General Hospital, Harvard Medical School, Boston, 10University of Delaware, Newark, DE, 11University of Delaware, New York, NY, 12University of California, San Francisco, San Francisco, CA, 13University of Alabama Birmingham, Birmingham, AL, 14University of Iowa, Iowa City, IA

    Background/Purpose: Patients with radiographic knee OA (rKOA) are at increased risk of mortality and walking difficulty may mediate this relation. Walking speed may be used…
  • Abstract Number: 0662 • ACR Convergence 2020

    Cause-Specific Mortality in Patients with Gout in the Veteran’s Health Administration: A Matched Cohort Study

    Lindsay Helget1, Bryant England1, Punyasha Roul1, Harlan Sayles1, Alison Petro1 and Ted Mikuls1, 1University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: Gout is the most common type of inflammatory arthritis, with a prevalence in the Veteran’s Health Administration (VHA) of nearly 6%.   While gout flares…
  • Abstract Number: 1476 • ACR Convergence 2020

    Trends in Mortality and Cause-specific Mortality Among Patients with Psoriasis and Psoriatic Arthritis in Ontario, Canada

    Keith Colaco1, Jessica Widdifield2, Jin Luo3, Cheryl Rosen4, Raed Alhusayen5, J. Michael Paterson6, Willemina Campbell7, Karen Tu4, Sasha Bernatsky8, Dafna Gladman9 and Lihi Eder10, 1Institute of Medical Science, University of Toronto; Women's College Research Institute, Women's College Hospital; and Toronto Western Hospital, University Health Network, Toronto, ON, Canada, 2University of Toronto - Toronto, Toronto, ON, Canada, 3ICES, Toronto, Toronto, ON, Canada, 4University of Toronto, Toronto, ON, Canada, 5Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada, 6ICES, University of Toronto, Toronto, ON, Canada, 7University Health Network, University of Toronto, Toronto, ON, Canada, 8The Research Institute of the McGill University Health Centre, Montreal, ON, Canada, 9Krembil Research Institute, Toronto Western Hospital, Toronto, ON, Canada, 10Women’s College Research Institute, University of Toronto, Toronto, ON, Canada

    Background/Purpose: Several studies have consistently demonstrated that psoriasis is associated with an increased risk of mortality compared to the general population. However, the excess risk…
  • Abstract Number: 0689 • ACR Convergence 2020

    The Changing Epidemiology of Inpatient Gout and Associated Mortality: A 17-year National Study

    Jasvinder Singh1 and John Cleveland1, 1University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Knowledge gaps exist regarding time-trends for the main causes (Cardiac/renal disease vs. infections) hospitalizations in gout. Therefore, we examined whether specific causes (cardiovascular, renal,…
  • Abstract Number: 1606 • ACR Convergence 2020

    Mortality with Idiopathic Inflammatory Myositis in an Academic Hospital Setting: A Five-year Retrospective Study

    Jaspreet Kaler1, Zareen Vaghaiwalla2, Gurjit Kaeley3 and Myint Thway4, 1University of Florida - Jacksonville, Jacksonville, FL, 2University of Florida Jacksonville, Jacksonville, FL, 3University of Florida College of Medicine - Jacksonville, Jacksonville, FL, 4University of Florida- Jacksonville, ponte vedra, FL

    Background/Purpose: Idiopathic inflammatory myositis is a diverse group of muscle diseases characterized by muscle inflammation and dysfunction. Approximately 3-7/100,000 cases are diagnosed per year in…
  • « Previous Page
  • 1
  • …
  • 18
  • 19
  • 20
  • 21
  • 22
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology